Abstract: Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, at least one anti-inflammatory agent, and one or more surfactants. Methods of making nanoemulsions and inactivating pathogenic microorganisms are also provided.

Abstract: Process for preparing a catalyst active for the fluid bed acetoxylation of ethylene to produce vinyl acetate.

Abstract: Apparatus and methods for treating tissue at or near a sphincter provide for transluminal introduction of an energy delivery device. The device includes a tissue compression member to compress target tissue at or near the sphincter. A radiofrequency energy source is coupleable to the delivery device to deliver radiofrequency energy to the target tissue. Energy is delivered to heat the tissue to a desired temperature. The desired temperature is selected to induce an injury-healing response or to inducing shrinkage of collagen fibers in the target tissue to thereby reduce laxity in the target tissue.

Abstract: The invention provides liquid toner compositions in which the polymeric binder is chemically grown in the form of copolymeric binder particles dispersed in a liquid carrier. The polymeric binder includes one amphipathic copolymer comprising one or more S material portions and one or more D material portions, wherein the D material portion has a Tg greater than about 55° C. The toners as described herein surprisingly provide compositions that are particularly suitable for electrophotographic processes wherein the transfer of the image from the surface of a photoconductor to an intermediate transfer material or directly to a print medium is carried out without film formation on the photoconductor.

Abstract: An infusion array ablation apparatus includes an elongated delivery device having a lumen and an infusion array positionable in the lumen. The infusion array includes an RF electrode and at least a first and a second infusion member. Each infusion member has a tissue piercing distal portion and an infusion lumen. At least one of the first or second infusion members is positionable in the elongated delivery device in a compacted state and deployable from the elongated delivery device with curvature in a deployed state. Also, at least one of the first or second infusion members exhibits a changing direction of travel when advanced from the elongated delivery device to a selected tissue site. At least one infusion port is coupled to one of the elongated delivery device, the infusion array, the first infusion member or the second infusion member.

Abstract: There is a urinary transfer system and associated process that includes a urinal capable of receiving urine from a patient, urine holding container, a first conduit connected between the urinal and the urine holding container, a pump, and a second conduit connected between the urine holding container and the pump. Preferably, there is a retainer that is associated with the urinal and a removable lid associated with the urine holding container. The urinary transfer system can be powered by any type of electrical power supply and/or battery. Optimally, there is a receiver electrically connected to the pump to be able to turn the pump on and off and can preferably control the operation of the pump based on input received from a transmitter. An external male catheter can also be utilized in conjunction with the urinary transfer system.

Abstract: Negative liquid electrographic toner compositions are provided comprising a liquid carrier having a Kauri-Butanol number less than about 30 mL and a plurality of negatively charged toner particles dispersed in the liquid carrier. The toner particles comprise a polymeric binder comprising at least one amphipathic graft copolymer comprising one or more S material portions and one or more D material portions. The toner composition additionally comprises a charge control adjuvant that is an acid or a base. These compositions have surprising bulk conductivity and charge per mass properties, particularly as the toner particles are depleted from the toner composition during printing operations.

Abstract: The invention includes methods, systems and devices for authenticating transactions. A method may begin by enrolling at least two biometric specimens to a database. A false acceptance ratio (“FAR”) is determined for each of the specimens, and authorization options are identified. A cost value is calculated for at least one of the options to provide a calculated cost value (“CCV”). The CCV may be a function of the FAR(s) of the specimen(s) corresponding to the option. An acceptable cost value range (“ACV range”) may be identified, and compared to the CCV. If it is determined that the CCV is in the ACV range, then the option is selected. If the CCV is in the ACV range, then a set of biometric samples is provided (the “sample set”). The sample set is compared to the biometric specimens, and it is determined whether the biometric samples match the biometric specimens. If the biometric samples match the biometric specimens, then the transaction is authorized.

Abstract: The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion compounds as mucosal adjuvants to induce immunity against environmental pathogens. Accordingly, in some embodiments, the present invention provides nanoemulsion vaccines comprising a nanoemulsion and an inactivated pathogen or protein derived from the pathogen. The present invention thus provides improved vaccines against a variety of environmental and human-released pathogens.

Abstract: As robust hinge post structure for use with torsional hinged devices such as micromirrors and method of manufacturing is disclosed. The fabrication process uses a protective layer such as BARC on the bottom of the aperture used to form the hinge post structure to protect an oxide layer during an etching step. The oxide layer, in turn protects the metal layer at the bottom of the aperture. Therefore, the metal layer, the oxide layer, and the protective layer prevent the erosion and/or pitting of the bottom electrode during a cleaning process, and provide additional support to the structure.

Abstract: The present invention relates to amphipathic copolymeric binder particles chemically grown in a substantially nonaqueous liquid carrier to form an organosol. The invention also pertains to dry particulate electrographic toners incorporating an organosol comprising an amphipathic copolymer wherein the amphipathic copolymer incorporates one or more S portions and one or more D portions. Methods of making dry electrophotographic toner particles, and methods of electrographically forming an image on a substrate using these toners, are also described. Preferably, fluidized drying techniques are used to form the dry toner particles from the organosol.

Abstract: Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfactants. Methods of making nanoemulsions and inactivating pathogenic microorganisms are also provided.

Abstract: An RF treatment apparatus includes a catheter with a catheter lumen. A removable needle electrode is positioned in the catheter lumen in a fixed relationship to the catheter. The needle electrode includes a needle lumen and a needle electrode distal end. A removable introducer is slidably positioned in the needle lumen. The introducer includes an introducer distal end. A first sensor is positioned on a surface of the needle electrode or the insulator. An RF power source is coupled to the needle electrode and a return electrode. An insulator sleeve is slidably positioned around the electrode and includes a second sensor. Resources are associated with the electrodes, sensors as well as the RF power source for maintaining a selected power at the electrode independent of changes in current or voltage.

Abstract: A wind power generating system that includes a series of progressively larger fan fans, the fans positioned in series relative to one another such that the blades of the trailing fans project into the wind stream that has been disturbed by the preceding fan and the undisturbed wind stream.

Abstract: A system for printing a liquid toner is provided comprising a liquid electrographic toner composition comprising a liquid carrier having a Kauri-Butanol number less than about 30 mL and a plurality of charged toner particles dispersed in the liquid carrier, wherein the toner particles comprise a polymeric binder. The system also comprises a charge control adjuvant having limited solubility in the liquid carrier. The charge control adjuvant preferably is present in the liquid carrier in an amount in excess of the solubility of the adjuvant in the liquid carrier. Alternatively, the charge control adjuvant may be dispersed in a matrix having limited solubility in the liquid carrier or encapsulated within a matrix to form microcapsules having limited solubility in the liquid carrier. The charge control adjuvant in any of the above forms may be provided in a number of formats for release into the toner composition as needed.

Abstract: A reentry vehicle includes a nose section, a modular section comprised of two or more connected modules, a flared section. The nose section is connected to a first end of the modular section, and the flared section is positioned proximate a second end of the modular cylindrical section.

Abstract: An electrosurgical medical device and method for creating thermal welds in engaged tissue. In one embodiment, at least one jaw of the instrument defines a tissue engagement plane carrying a conductive-resistive matrix of a conductively-doped non-conductive elastomer. The engagement surface portions thus can be described as a positive temperature coefficient material that has a unique selected decreased electrical conductance at each selected increased temperature thereof over a targeted treatment range. The conductive-resistive matrix can be engineered to bracket a targeted thermal treatment range, for example about 60° C. to 80° C., at which tissue welding can be accomplished. In one mode of operation, the engagement plane will automatically modulate and spatially localize ohmic heating within the engaged tissue from Rf energy application—across micron-scale portions of the engagement surface.

Abstract: The present invention includes a method of deciding whether a data set is acceptable for making a decision. A first probability partition array and a second probability partition array may be provided. A no-match zone may be established and used to calculate a false-acceptance-rate (“FAR”) and/or a false-rejection-rate (“FRR”) for the data set. The FAR and/or the FAR may be compared to desired rates. Based on the comparison, the data set may be either accepted or rejected. The invention may also be embodied as a computer readable memory device for executing the methods.

Abstract: Dry electrographic toner particles are provided that comprise at least one visual enhancement additive encapsulated within an amphipathic copolymer. The amphipathic copolymer comprises one or more S portions and one or more D portions. Methods of making and methods of using these toner particles are also provided.